首页> 外文会议>Nano Science and Technology Institute Nanotechnology Conference and Trade Show >Nanoemulsion Formulations for Improved Oral Delivery of Poorly Soluble Drugs
【24h】

Nanoemulsion Formulations for Improved Oral Delivery of Poorly Soluble Drugs

机译:纳米乳剂配方,用于改善难溶性药物的口服递送

获取原文

摘要

The objective of this study was to develop nanoemulsion formulations for enhancement of oral bioavailability of paclitaxel, a model hydrophobic drug and P-glycoprotein substrate. The oil-in-water (o/w) nanoemulsions were made with pine nut oil as the internal oil phase, egg lecithin as the primary emulsifier, and water as the external phase. Stearylamine and deoxycholic acid were used to impart positive and negative charge to the emulsions, respectively. The formulated nanoemulsions had a particle size range of 90-120 nm and zeta potential ranging from +34 mV to -56 mV. Following oral administration to C57BL/6 mice, a significantly higher concentration of paclitaxel was observed in the systemic circulation when administered in the nanoemulsion relative to control aqueous solution. The results of this study suggest that nanoemulsions are promising novel formulations that can enhance the oral bioavailability of poorly soluble drugs.
机译:本研究的目的是开发纳米乳液制剂以提高紫杉醇的口服生物利用度,模型疏水药物和糖蛋白基材。用松果油作为内部油相,蛋卵磷脂作为初级乳化剂,以及作为外部阶段的水的水包油纳米乳液。硬脂胺和脱氧胆酸分别赋予乳液的正和负电荷。配制的纳米乳液的粒度范围为90-120nm,Zeta电位范围为+ 34mV至-56mV。在口服给予C57BL / 6小鼠后,在相对于对照水溶液中施用纳米乳剂时,在全身循环中观察到显着较高的紫杉醇。该研究的结果表明,纳米乳液是有前途的新配方,可以增强可溶性药物的口腔生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号